Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund Assets
Net Assets - Class R6

Portfolio Details

Asset AllocationAs of 12/31/2020

[name] [value]
Equity 97.98%
Cash & Cash Equivalents 2.02%

Geographic BreakdownAs of 12/31/2020

[name] [value]
United States 87.11%
United Kingdom 3.59%
Canada 2.58%
Denmark 2.42%
Cash & Cash Equivalents 2.02%
Switzerland 1.30%
Netherlands 0.98%

sector breakdownAs of 12/31/2020

[name] [value]
Biotechnology 79.87%
Pharmaceuticals 12.88%
Life Sciences Tools & Services 3.97%
Cash & Cash Equivalents 2.02%
Diversified Capital Markets 0.97%
Other Diversified Financial Services 0.29%

TOP TEN HOLDINGSAs of 12/31/2020

Issuer Country Industry % of total
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.73%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.65%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.87%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.76%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.21%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.97%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.45%
PTC THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.04%
SEAGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.68%
HORIZON PHARMA PLC United States Pharmaceuticals, Biotechnology & Life Sciences 2.60%

Market Capitalization BreakdownAs of 12/31/2020

[name] [value]
<2.0 Billion 20.84%
2.0-5.0 Billion 20.52%
5.0-10.0 Billion 18.76%
10.0-25.0 Billion 7.05%
25.0-50.0 Billion 7.26%
>50.0 Billion 25.49%
N/A 0.07%